LM
ASPN icon

Luminus Management’s Aspen Aerogels ASPN Stock Holding History

Luminus Management’s Portfolio ASPN Stock Details ASPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,300
Closed -$861K – 22
2021
Q4 		$861K Buy
+17,300
New +$912K 0.2% 53

Other funds holding ASPN

SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
GKFF
George Kaiser Family Foundation Tulsa, Oklahoma $883M AUM 21.04% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
KI
Koch Industries Wichita, Kansas $853M AUM 37.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Luminus Management's ASPN Position: Q1 2022 in Review

Luminus Management sold out of Aspen Aerogels (ASPN) in Q1 2022, closing a stake of 17,300 shares — an estimated $861K sold.

Luminus Management first reported a position in ASPN in Q4 2021 and held it in 1 quarter. The position peaked at $861K in Q4 2021. 145 funds tracked by Wall St. Rank hold ASPN as of Q1 2022.

  • Luminus Management reported no remaining Aspen Aerogels position as of Q1 2022 after selling out during the quarter.
  • Luminus Management sold 17,300 Aspen Aerogels shares in Q1 2022, an estimated $861K.
  • Luminus Management first reported a position in Aspen Aerogels in Q4 2021 and held it in 1 quarter.
  • Luminus Management's Aspen Aerogels position peaked at $861K in Q4 2021.
  • 145 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2022.

Based on Luminus Management's 13F filing for Q1 2022, filed 13 May 2022.